More on: enhanced thrombin generation in patients with cirrhosis-induced coagulopathy.
A
A
Tripodi
M
M
Primignani
V
V
Chantarangkul
P M
PM
Mannucci
D000925:Anticoagulants / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000097:blood* / Q000188:drug therapy / Q000209:etiology*; D004351:Drug Resistance; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008103:Liver Cirrhosis / Q000097:blood* / Q000150:complications*; D010455:Peptides / Q000627:therapeutic use; D013917:Thrombin / Q000096:biosynthesis*; D018180:Thrombomodulin / Q000627:therapeutic use
D000925:Anticoagulants; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C546931:THBD protein, human; D018180:Thrombomodulin; C049647:snake venom protein C activator; D013917:Thrombin